Cart
sales@molnova.com
Cimigenoside
CAS No. 27994-11-2
Cimigenoside( —— )
Catalog No. M18356 CAS No. 27994-11-2
Cimigenoside is an active compound from genus Cimicifuga.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 103 | In Stock |
|
| 5MG | 67 | In Stock |
|
| 10MG | 96 | In Stock |
|
| 25MG | 162 | In Stock |
|
| 50MG | 233 | In Stock |
|
| 100MG | 347 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCimigenoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionCimigenoside is an active compound from genus Cimicifuga.
-
DescriptionCimigenoside is an active compound from genus Cimicifuga.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number27994-11-2
-
Formula Weight620.82
-
Molecular FormulaC35H56O9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (161.08 mM)
-
SMILESCC1CC2C(OC3(C1C4(CCC56CC57CCC(C(C7CCC6C4(C3O)C)(C)C)OC8C(C(C(CO8)O)O)O)C)O2)C(C)(C)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Oritinib
Oritinib is an inhibitor of EGFR with IC50s of 18, 0.7, 4, 0.1, 1.4 and 0.89 nM for EGFR (wt), EGFR (L858R), EGFR (L861Q), EGFR (L858R/T790M), EGFR (d746-750), EGFR (d746-750/T790M), respectively. Oritinib can be used in studies about the treatment of non-small cell lung cancer.
-
Rezivertinib
Rezivertinib (BPI-7711) is an orally available, selective and potent inhibitor of tyrosine kinase (EGFR) with antitumor activity for central nervous system disorders.
-
EGFR/ErbB-2 inhibito...
EGFR/ErbB-2 inhibitor-1 is a selective ErbB2/HER2 inhibitor that effectively blocks ErbB2 and HER2 signaling.
